{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:45:30Z","timestamp":1777401930694,"version":"3.51.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>According to Barcelona Clinic Liver Cancer classification, transarterial chemoembolization (TACE) is preferred treatment for stage B and in certain cases for stage A hepatocellular carcinoma (HCC). Conventional TACE (c-TACE) and drug-eluting microspheres TACE (DEM-TACE) are available intraarterial therapies. Screening of patients with cirrhosis is of great importance for early detection of malignant liver nodules. Primary endpoint of this study was to compare DEM-TACE with c-TACE in terms of 12- and 24-month survival. Secondary endpoints were comparison of intensity and duration of the postembolization syndrome (PES) and severe adverse events. We randomized 60 patients with unresectable HCC one-to-one with c-TACE or DEM-TACE and followed them for at least 24 months or until death. TACE was repeated \u2018on-demand. Most patients underwent two TACE sessions and the median hospital stay was 3\u2009days for c-TACE and 2\u2009days for DEM-TACE group. The overall 12- and 24-month survival rates were 89.8 and 70.7%, respectively, precisely 85.7 and 63.6% after c-TACE and 90.2 and 75.8% after DEM-TACE, without any significant difference (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.18). Median overall survival was 21.1\u2009months. Significant difference in the overall 12- and 24-month survival was found in patients with Child-Pugh A compared to Child-Pugh B class (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.001). Child-Pugh class, aspartate aminotransferase levels and ascites independently predicted survival (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.003). Both, DEM-TACE and c-TACE showed excellent 12- and 24-month survival rates. No significant difference in terms of adverse events was found. PES was slightly more severe after c-TACE, because of elevated temperature. DEM-TACE requires shorter in-hospital stay.<\/jats:p>","DOI":"10.1097\/cej.0000000000000623","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T20:04:27Z","timestamp":1602273867000},"page":"258-266","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Single-center randomized trial comparing conventional chemoembolization versus doxorubicin-loaded polyethylene glycol microspheres for early- and intermediate-stage hepatocellular carcinoma"],"prefix":"10.1097","volume":"30","author":[{"given":"Aleksandar","family":"Gjoreski","sequence":"first","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivona","family":"Jovanoska","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Risteski","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Prgova Veljanova","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dane","family":"Nedelkovski","sequence":"additional","affiliation":[{"name":"Department of Abdominal Surgery, City General Hospital \u201c8th September\u201d"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Dimov","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Acibadem Sistina Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozalinda","family":"Popova Jovanovska","sequence":"additional","affiliation":[{"name":"University Clinic of Gastroenterohepatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Grozdanovska Angelovska","sequence":"additional","affiliation":[{"name":"University Clinic of Radiotherapy and Oncology, \u201cSt. Cyril and Methodius\u201d University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenad","family":"Mitrevski","sequence":"additional","affiliation":[{"name":"University Clinic of Radiotherapy and Oncology, \u201cSt. Cyril and Methodius\u201d University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Dimova","sequence":"additional","affiliation":[{"name":"Department of Pathology, Acibadem Sistina Hospital, Skopje, North Macedonia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00270-013-0656-5","article-title":"Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.","volume":"37","author":"Bargellini","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update.","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","article-title":"Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolization (TACE) using DC beads. Implications for clinical practice and trial design.","volume":"56","author":"Burrel","year":"2012","journal-title":"J Hepatol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.21522","article-title":"Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).","volume":"101","author":"Dhanasekaran","year":"2010","journal-title":"J Surg Oncol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1053\/j.gastro.2004.09.022","article-title":"Issues in screening and surveillance for hepatocellular carcinoma.","volume":"127","author":"Di Bisceglie","year":"2004","journal-title":"Gastroenterology"},{"key":"R10-20250527","first-page":"j182","article-title":"Management of hepatocellular carcinoma: an update.","volume":"69","year":"2018","journal-title":"J Hepatology"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma.","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2214\/ajr.172.1.9888740","article-title":"Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response.","volume":"172","author":"Ernst","year":"1999","journal-title":"Am J Roentgenol"},{"key":"R16-20250527","first-page":"813","article-title":"Doxorubicin-eluting bead versus conventional TACE for unresectable hepatocellular carcinoma: a meta-analysis.","volume":"60","author":"Gao","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.","volume":"111","author":"Golfieri","year":"2014","journal-title":"Br J Cancer"},{"key":"R18-20250527","first-page":"1002","article-title":"Meta-analysis of doxorubicin eluting beads via transcatheter arterial chemoembolization in the treatment of unresectable hepatocellular carcinoma.","volume":"62","author":"Hui","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00270-012-0394-0","article-title":"Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.","volume":"35","author":"Malagari","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00270-017-1839-2","article-title":"Safety and feasibility of chemoembolization with doxorubicin-loaded small calibrated microspheres in patients with hepatocellular carcinoma: results of the miracle I prospective multicentre study.","volume":"41","author":"Richter","year":"2018","journal-title":"Cardiovasc Radiol"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jvir.2011.07.002","article-title":"Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.","volume":"22","author":"Sacco","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1756-9966-29-164","article-title":"Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis.","volume":"29","author":"Scartozzi","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jhep.2012.07.017","article-title":"Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.","volume":"57","author":"Song","year":"2012","journal-title":"J Hepatol"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jhep.2011.10.021","article-title":".","volume":"56","author":"Takayasu","year":"2012","journal-title":"J Hepatol"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.","volume":"46","author":"Varela","year":"2007","journal-title":"J Hepatol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:03:15Z","timestamp":1748361795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000623","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}